Lechi Vo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lechi Vo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Peter D. Drummond
School of Psychology and Centre for Healthy Ageing, Murdoch University, Western Australia, Australia
12 shared publications - Di Ye
School of Psychology and Centre for Healthy Ageing, Murdoch University, Western Australia, Australia
4 shared publications - Timothy John Fairchild
School of Allied Health, College of Health and Education, Murdoch University, Perth, Australia
2 shared publications Ashlea Bell
Murdoch University
1 shared publicationHakuei Fujiyama
College of Science, Health, Engineering and Education, Discipline of Psychology Murdoch University, Perth, Australia
1 shared publication- Matthew Carabetta
School of Psychology and Centre for Healthy Ageing, College of Health and Education, Murdoch University, 90 South Street, Murdoch, Western Australia 6150, Australia
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Pain Research and Management
- Vol. 2025 (1) , 6601529
Ultraviolet B Treatment of the Forearm Alters Supraspinal Nociceptive Processing
Exposing the skin to high levels of ultraviolet B (UVB) radiation induces an inflammatory response that upregulates local nociceptive processing; this, in turn, facilitates protective responses to limit further injury. In this study, the UVB model was used to explore additional effects of inflammation on supraspinal nociceptive processing. Thirty‐one healthy participants attended two sessions approximately 24 h apart. In each session, pressure‐pain thresholds and sensitivity to sharp stimulation and heat were assessed in both forearms, and pressure‐pain thresholds and sensitivity to sharp stimulation were assessed on each side of the forehead. In a novel paradigm, supraspinal nociceptive processing was explored by assessing pain and blink reflexes to electrical stimulation of the forehead, paired with acoustic startle stimuli. At the end of the first session, UVB radiation at a dose sufficient to induce erythema at the most exposed site was administered to one forearm. Consistent with local sensitization, sensitivity to heat and sharp stimulation had increased at the maximally exposed site 24 h later. This local response was accompanied by changes in supraspinal nociceptive processing—pressure‐pain thresholds were lower on the ipsilateral than contralateral side of the forehead, and acoustic startle stimuli augmented electrically evoked pain. Blink reflexes weakened from the first to the second session, but decreases were smaller on the UVB‐treated than contralateral side. Together, these findings suggest that acoustic startle stimuli facilitated activity in sensitized supraspinal nociceptive pathways. Potentially, this supraspinal mechanism adds to the burden of chronic nociplastic pain during states of heightened arousal and stress.
- 1 January 2025
- Published by Wiley in Pain Research and Management
- Vol. 2025 (1) , 6601529
Open AccessUltraviolet B Treatment of the Forearm Alters Supraspinal Nociceptive Processing
Exposing the skin to high levels of ultraviolet B (UVB) radiation induces an inflammatory response that upregulates local nociceptive processing; this, in turn, facilitates protective responses to limit further injury. In this study, the UVB model was used to explore additional effects of inflammation on supraspinal nociceptive processing. Thirty‐one healthy participants attended two sessions approximately 24 h apart. In each session, pressure‐pain thresholds and sensitivity to sharp stimulation and heat were assessed in both forearms, and pressure‐pain thresholds and sensitivity to sharp stimulation were assessed on each side of the forehead. In a novel paradigm, supraspinal nociceptive processing was explored by assessing pain and blink reflexes to electrical stimulation of the forehead, paired with acoustic startle stimuli. At the end of the first session, UVB radiation at a dose sufficient to induce erythema at the most exposed site was administered to one forearm. Consistent with local sensitization, sensitivity to heat and sharp stimulation had increased at the maximally exposed site 24 h later. This local response was accompanied by changes in supraspinal nociceptive processing—pressure‐pain thresholds were lower on the ipsilateral than contralateral side of the forehead, and acoustic startle stimuli augmented electrically evoked pain. Blink reflexes weakened from the first to the second session, but decreases were smaller on the UVB‐treated than contralateral side. Together, these findings suggest that acoustic startle stimuli facilitated activity in sensitized supraspinal nociceptive pathways. Potentially, this supraspinal mechanism adds to the burden of chronic nociplastic pain during states of heightened arousal and stress.
- 6 September 2024
- Published by Elsevier in The Journal of Pain
- Vol. 25 (12) , 104670
Comparable Conditioned Pain Modulation and Painful-Exercise-Induced Hypoalgesia in Healthy Young Adults: A Randomized Crossover Trial
- 6 September 2024
- Published by Elsevier in The Journal of Pain
- Vol. 25 (12) , 104670
Comparable Conditioned Pain Modulation and Painful-Exercise-Induced Hypoalgesia in Healthy Young Adults: A Randomized Crossover Trial
- 6 May 2024
- Published by Elsevier in The Journal of Pain
- Vol. 25 (9) , 104553
Hyperglycemia and Central Obesity Disrupt Conditioned Pain Modulation: A Single-Blind Crossover Randomized Controlled Trial
- 6 May 2024
- Published by Elsevier in The Journal of Pain
- Vol. 25 (9) , 104553
Hyperglycemia and Central Obesity Disrupt Conditioned Pain Modulation: A Single-Blind Crossover Randomized Controlled Trial
- 16 September 2022
- Published by Elsevier in The Journal of Pain
- Vol. 24 (1) , 128-144
High Blood Glucose and Excess Body fat Enhance Pain Sensitivity and Weaken Pain Inhibition in Healthy Adults: A Single-blind Cross-over Randomized Controlled Trial
- 16 September 2022
- Published by Elsevier in The Journal of Pain
- Vol. 24 (1) , 128-144
High Blood Glucose and Excess Body fat Enhance Pain Sensitivity and Weaken Pain Inhibition in Healthy Adults: A Single-blind Cross-over Randomized Controlled Trial
- 1 February 2022
- Published by Elsevier in The Journal of Pain
- Vol. 23 (2) , 305-317
Anodal Transcranial Direct Current Stimulation Reduces Secondary Hyperalgesia Induced by low Frequency Electrical Stimulation in Healthy Volunteers
- 1 February 2022
- Published by Elsevier in The Journal of Pain
- Vol. 23 (2) , 305-317
Anodal Transcranial Direct Current Stimulation Reduces Secondary Hyperalgesia Induced by low Frequency Electrical Stimulation in Healthy Volunteers
- 21 October 2021
- Published by Wiley in Diabetic Medicine
- Vol. 39 (1) , e14729
Painful diabetic peripheral neuropathy: Role of oxidative stress and central sensitisation
Aims: Diabetic peripheral neuropathy (DPN) occurs in about half of people with diabetes, of whom a quarter may develop chronic pain. Pain may remain for years yet be difficult to treat because the underlying mechanisms remain unclear. There is consensus that processing excessive glucose leads to oxidative stress, interfering with normal metabolism. In this narrative review, we argue that oxidative stress may also contribute to pain.Methods: We reviewed literature in PubMed published between January 2005 and August 2021.Results and conclusions: In diabetes, hyperglycaemia and associated production of reactive species can directly increase pain signalling and activate sensory neurons; or the effects can be indirect, mediated by mitochondrial damage and enhanced inflammation. Furthermore, pain processing in the central nervous system is compromised in painful DPN. This is implicated in central sensitisation and dysfunctional pain modulation. However, central pain modulatory function is understudied in diabetes. Future research is required to clarify whether central sensitisation and/or disturbances in central pain modulation contribute to painful DPN. Positive results would facilitate early detection and future treatment.
- 21 October 2021
- Published by Wiley in Diabetic Medicine
- Vol. 39 (1) , e14729
Painful diabetic peripheral neuropathy: Role of oxidative stress and central sensitisation
Aims: Diabetic peripheral neuropathy (DPN) occurs in about half of people with diabetes, of whom a quarter may develop chronic pain. Pain may remain for years yet be difficult to treat because the underlying mechanisms remain unclear. There is consensus that processing excessive glucose leads to oxidative stress, interfering with normal metabolism. In this narrative review, we argue that oxidative stress may also contribute to pain.Methods: We reviewed literature in PubMed published between January 2005 and August 2021.Results and conclusions: In diabetes, hyperglycaemia and associated production of reactive species can directly increase pain signalling and activate sensory neurons; or the effects can be indirect, mediated by mitochondrial damage and enhanced inflammation. Furthermore, pain processing in the central nervous system is compromised in painful DPN. This is implicated in central sensitisation and dysfunctional pain modulation. However, central pain modulatory function is understudied in diabetes. Future research is required to clarify whether central sensitisation and/or disturbances in central pain modulation contribute to painful DPN. Positive results would facilitate early detection and future treatment.
- 12 May 2018
- Published by Springer Nature in Experimental Brain Research
- Vol. 236 (7) , 2097-2105
Painful stimulation of a sensitized site in the forearm inhibits ipsilateral trigeminal nociceptive blink reflexes
Exposure to moderate levels of ultraviolet B radiation (UVB) is painless but nevertheless induces an inflammatory response that sensitizes primary afferent nociceptors. Subsequently, heating the UVB-treated site can sensitize spinal nociceptors. We used a repeated-measures design to determine whether heating the UVB-treated site also triggers ipsilateral inhibitory controls. Specifically, a 2-cm diameter site on the forearm of 20 participants was exposed to UVB at twice the minimum erythema dose. 48 h later mechanical and thermal sensitivity had increased at the UVB-treated site, indicating primary hyperalgesia. In addition, sensitivity to blunt pressure had increased in the ipsilateral forehead, implying activation of an ipsilateral supra-spinal pro-nociceptive mechanism. Despite this, the area under the curve of the ipsilateral nociceptive blink reflex decreased when the UVB-treated site was heated to induce moderate pain. Together, these findings suggest that the UVB treatment sensitized primary nociceptive afferents and generated an ipsilateral supra-spinal pro-nociceptive mechanism. In addition, sensitization to heat induced by the UVB treatment strengthened an ipsilateral anti-nociceptive process elicited by heat-pain. Infrequent but enduring discharge of sensitized primary nociceptive afferents, driven by inflammation after UVB exposure, might initiate a lateralized supra-spinal pro-nociceptive influence that heightens awareness of impending harm on the sensitized side of the body. In addition, a lateralized anti-nociceptive response triggered by an intense barrage of nociceptive signals may help to differentiate stronger from weaker sources of pain.
- 12 May 2018
- Published by Springer Nature in Experimental Brain Research
- Vol. 236 (7) , 2097-2105
Painful stimulation of a sensitized site in the forearm inhibits ipsilateral trigeminal nociceptive blink reflexes
Exposure to moderate levels of ultraviolet B radiation (UVB) is painless but nevertheless induces an inflammatory response that sensitizes primary afferent nociceptors. Subsequently, heating the UVB-treated site can sensitize spinal nociceptors. We used a repeated-measures design to determine whether heating the UVB-treated site also triggers ipsilateral inhibitory controls. Specifically, a 2-cm diameter site on the forearm of 20 participants was exposed to UVB at twice the minimum erythema dose. 48 h later mechanical and thermal sensitivity had increased at the UVB-treated site, indicating primary hyperalgesia. In addition, sensitivity to blunt pressure had increased in the ipsilateral forehead, implying activation of an ipsilateral supra-spinal pro-nociceptive mechanism. Despite this, the area under the curve of the ipsilateral nociceptive blink reflex decreased when the UVB-treated site was heated to induce moderate pain. Together, these findings suggest that the UVB treatment sensitized primary nociceptive afferents and generated an ipsilateral supra-spinal pro-nociceptive mechanism. In addition, sensitization to heat induced by the UVB treatment strengthened an ipsilateral anti-nociceptive process elicited by heat-pain. Infrequent but enduring discharge of sensitized primary nociceptive afferents, driven by inflammation after UVB exposure, might initiate a lateralized supra-spinal pro-nociceptive influence that heightens awareness of impending harm on the sensitized side of the body. In addition, a lateralized anti-nociceptive response triggered by an intense barrage of nociceptive signals may help to differentiate stronger from weaker sources of pain.
- 7 February 2017
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 31 (6) , 722-729
Effect of combined opioid receptor and α2-adrenoceptor blockade on anxiety and electrically evoked startle responses
The R3 component of the electrically evoked blink reflex may form part of a startle reaction. Acoustic startle responses are augmented by yohimbine, an α2-adrenoceptor antagonist that blocks α2-autoreceptors, and are potentiated by opioid receptor blockade. To investigate these influences on electrically evoked startle responses, 16 mg yohimbine, with (16 participants) or without 50 mg naltrexone (23 participants), was administered in separate double-blind placebo-controlled cross-over experiments. In each experiment, R3 (a probable component of the startle response) was examined before and after high-frequency electrical stimulation of the forearm, a procedure that initiates inhibitory pain controls. Anxiety and somatic symptoms were greater after yohimbine than placebo, and were potentiated by naltrexone. Pain ratings for the electrically evoked startle stimuli decreased after high-frequency electrical stimulation in the placebo session but remained stable after drug administration. Yohimbine with naltrexone, but not yohimbine alone, also blocked an inhibitory effect of high-frequency electrical stimulation on electrically evoked sharp sensations and R3. Together, the findings suggest that adding naltrexone to yohimbine potentiated anxiety and blocked inhibitory influences of high-frequency electrical stimulation on electrically evoked sensations and startle responses. Thus, opioid peptides could reduce activity in nociceptive and startle-reflex pathways, or inhibit crosstalk between these pathways. Failure of this inhibitory opioid influence might be important in chronically painful conditions that are aggravated by startle stimuli.
- 7 February 2017
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 31 (6) , 722-729
Effect of combined opioid receptor and α2-adrenoceptor blockade on anxiety and electrically evoked startle responses
The R3 component of the electrically evoked blink reflex may form part of a startle reaction. Acoustic startle responses are augmented by yohimbine, an α2-adrenoceptor antagonist that blocks α2-autoreceptors, and are potentiated by opioid receptor blockade. To investigate these influences on electrically evoked startle responses, 16 mg yohimbine, with (16 participants) or without 50 mg naltrexone (23 participants), was administered in separate double-blind placebo-controlled cross-over experiments. In each experiment, R3 (a probable component of the startle response) was examined before and after high-frequency electrical stimulation of the forearm, a procedure that initiates inhibitory pain controls. Anxiety and somatic symptoms were greater after yohimbine than placebo, and were potentiated by naltrexone. Pain ratings for the electrically evoked startle stimuli decreased after high-frequency electrical stimulation in the placebo session but remained stable after drug administration. Yohimbine with naltrexone, but not yohimbine alone, also blocked an inhibitory effect of high-frequency electrical stimulation on electrically evoked sharp sensations and R3. Together, the findings suggest that adding naltrexone to yohimbine potentiated anxiety and blocked inhibitory influences of high-frequency electrical stimulation on electrically evoked sensations and startle responses. Thus, opioid peptides could reduce activity in nociceptive and startle-reflex pathways, or inhibit crosstalk between these pathways. Failure of this inhibitory opioid influence might be important in chronically painful conditions that are aggravated by startle stimuli.
- 1 November 2016
- Published by Elsevier in The Journal of Pain
- Vol. 17 (11) , 1164-1173
Involvement of Opioid Receptors and α2-Adrenoceptors in Inhibitory Pain Modulation Processes: A Double-Blind Placebo-Controlled Crossover Study
- 1 November 2016
- Published by Elsevier in The Journal of Pain
- Vol. 17 (11) , 1164-1173
Involvement of Opioid Receptors and α2-Adrenoceptors in Inhibitory Pain Modulation Processes: A Double-Blind Placebo-Controlled Crossover Study
- 29 May 2015
- Published by Wiley in European journal of pain
- Vol. 20 (3) , 386-398
Involvement of α2‐adrenoceptors in inhibitory and facilitatory pain modulation processes
Background: In healthy humans, high‐frequency electrical stimulation (HFS) of the forearm not only produces hyperalgesia at the site of stimulation but also reduces sensitivity to pressure‐pain on the ipsilateral side of the forehead. In addition,HFSaugments the ipsilateral trigeminal nociceptive blink reflex and intensifies the ipsilateral component of conditioned pain modulation. The aim of this study was to determine whether α2‐adrenoceptors mediate these ipsilateral nociceptive influences.Methods: The α2‐adrenoceptor antagonist yohimbine was administered to 22 participants in a double‐blind, placebo‐controlled crossover study. In each session, thermal and mechanical sensitivity in the forearms and forehead was assessed before and afterHFS. In addition, the combined effect ofHFSand yohimbine on the nociceptive blink reflex and on conditioned pain modulation was explored. In this paradigm, the conditioning stimulus was cold pain in the ipsilateral or contralateral temple, and the test stimulus was electrically evoked pain in the forearm.Results: Blood pressure and electrodermal activity increased for several hours after yohimbine administration, consistent with blockade of central α2‐adrenoceptors. Yohimbine not only augmented the nociceptive blink reflex ipsilateral toHFSbut also intensified the inhibitory influence of ipsilateral temple cooling on electrically evoked pain at theHFS‐treated site in the forearm. Yohimbine had no consistent effect on primary or secondary hyperalgesia in the forearm or on pressure‐pain in the ipsilateral forehead.Conclusions: These findings imply involvement of α2‐adrenoceptors both in ipsilateral antinociceptive and pronociceptive pain modulation processes. However, a mechanism not involving α2‐adrenoceptors appears to mediate analgesia in the ipsilateral forehead afterHFS.
- 29 May 2015
- Published by Wiley in European journal of pain
- Vol. 20 (3) , 386-398
Involvement of α2‐adrenoceptors in inhibitory and facilitatory pain modulation processes
Background: In healthy humans, high‐frequency electrical stimulation (HFS) of the forearm not only produces hyperalgesia at the site of stimulation but also reduces sensitivity to pressure‐pain on the ipsilateral side of the forehead. In addition,HFSaugments the ipsilateral trigeminal nociceptive blink reflex and intensifies the ipsilateral component of conditioned pain modulation. The aim of this study was to determine whether α2‐adrenoceptors mediate these ipsilateral nociceptive influences.Methods: The α2‐adrenoceptor antagonist yohimbine was administered to 22 participants in a double‐blind, placebo‐controlled crossover study. In each session, thermal and mechanical sensitivity in the forearms and forehead was assessed before and afterHFS. In addition, the combined effect ofHFSand yohimbine on the nociceptive blink reflex and on conditioned pain modulation was explored. In this paradigm, the conditioning stimulus was cold pain in the ipsilateral or contralateral temple, and the test stimulus was electrically evoked pain in the forearm.Results: Blood pressure and electrodermal activity increased for several hours after yohimbine administration, consistent with blockade of central α2‐adrenoceptors. Yohimbine not only augmented the nociceptive blink reflex ipsilateral toHFSbut also intensified the inhibitory influence of ipsilateral temple cooling on electrically evoked pain at theHFS‐treated site in the forearm. Yohimbine had no consistent effect on primary or secondary hyperalgesia in the forearm or on pressure‐pain in the ipsilateral forehead.Conclusions: These findings imply involvement of α2‐adrenoceptors both in ipsilateral antinociceptive and pronociceptive pain modulation processes. However, a mechanism not involving α2‐adrenoceptors appears to mediate analgesia in the ipsilateral forehead afterHFS.